Jose Ferrer Rebolleda, Medical Director of ERESA, describes his experience with MAMMI dedicated breast PET (MammiPET)

When it comes to talking about mammo-dedicated technology, MammiPET is an important step forward in the early detection of breast cancer. It has been proven to be a very reliable system in our Nuclear Medicine Department. ERESA is located in the General University Hospital of Valencia, where more than 400 patients have been already benefited from its use.

Thanks to the high resolution provided by Mammi, we can locate very small tumors, which guarantees the patient an earlier and more efficient diagnosis. This difference can be clearly seen when Mammi PET is compared to other techniques, such as mammography, ultrasound or MRI. While the conventional technique localizes tumor masses as a function of the alteration in tissue shape, the use of Mammi allows you to find tumors measuring even less than 3-4 mm in size by focusing on assessing cellular functionality. Accuracy is an important factor when we talk about processes linked to the development of cancer cells.

On the other hand, MammiPET is also a guarantee for patients, since the images it generates help significantly reduce false positive cases. This allows us to avoid unnecessary tests, and to quickly resolve any possible contradictory evidence, which, in the long run, has a positive impact on the patient’s quality of care, and reduces their uncertainty in a very delicate situation, in which a diagnosis of cancer is a possibility.
Beside these technical characteristics, the external design and configuration of Mammi also provides benefits for women who undergo this type of tomography, thanks to its ergonomic prone position without compression. Taking care of these factors, such as patient comfort, is something that is often forgotten, but most specialists consider it to be added value to the equipment.
To summarize, we are faced with an innovation that opens the door to new possibilities in breast cancer diagnostic imaging and in the personalization of the subsequent treatment.